SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
-13.51%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$561M
AUM Growth
+$561M
Cap. Flow
+$45.2M
Cap. Flow %
8.06%
Top 10 Hldgs %
86.32%
Holding
44
New
1
Increased
3
Reduced
8
Closed
7

Top Buys

1
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
$91.3M
2
MLYS icon
Mineralys Therapeutics
MLYS
$9.53M
3
SRZN icon
Surrozen
SRZN
$2.81M
4
SEPN
Septerna, Inc. Common Stock
SEPN
$2.2M

Top Sells

1
JSPR icon
Jasper Therapeutics
JSPR
$12.5M
2
LENZ
LENZ Therapeutics
LENZ
$11.8M
3
ACLX icon
Arcellx
ACLX
$7.76M
4
ACRS icon
Aclaris Therapeutics
ACRS
$5.91M
5
CLYM
Climb Bio, Inc. Common Stock
CLYM
$4.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TNGX icon
26
Tango Therapeutics
TNGX
$747M
$863K 0.15% 630,000 – –
PRME icon
27
Prime Medicine
PRME
$578M
$806K 0.14% 405,228 – –
LPTX icon
28
Leap Therapeutics
LPTX
$12M
$745K 0.13% 2,442,352 – –
HLVX icon
29
HilleVax
HLVX
$105M
$579K 0.1% 399,637 – –
TERN icon
30
Terns Pharmaceuticals
TERN
$609M
$558K 0.1% 202,348 – –
BOLT icon
31
Bolt Biotherapeutics
BOLT
$9.85M
$420K 0.07% 1,049,153 – –
CRIS icon
32
Curis
CRIS
$20.9M
$390K 0.07% 185,943 -12,273 -6% -$25.8K
LYRA icon
33
Lyra Therapeutics
LYRA
$11.5M
$176K 0.03% 1,390,130 -575,559 -29% -$72.7K
KRON
34
DELISTED
Kronos Bio
KRON
$64.5K 0.01% 78,131 – –
NUVB.WS icon
35
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$42.7K 0.01% 133,333 – –
ALLK
36
DELISTED
Allakos
ALLK
$39.2K 0.01% 172,089 – –
SRZNW icon
37
Surrozen, Inc. Warrant
SRZNW
$71.6K
$3K ﹤0.01% 99,999 – –
ACRS icon
38
Aclaris Therapeutics
ACRS
$209M
– – -2,385,060 Closed -$5.91M
DAWN icon
39
Day One Biopharmaceuticals
DAWN
$769M
– – -147,319 Closed -$1.87M
IMTX icon
40
Immatics
IMTX
$619M
– – -198,000 Closed -$1.41M
JANX icon
41
Janux Therapeutics
JANX
$1.37B
– – -11,263 Closed -$603K
JSPR icon
42
Jasper Therapeutics
JSPR
$45.5M
– – -584,642 Closed -$12.5M
VRNA
43
Verona Pharma
VRNA
$9.16B
– – -97,625 Closed -$4.53M
CLYM
44
Climb Bio, Inc. Common Stock
CLYM
$151M
– – -2,609,114 Closed -$4.7M
1
2